Freeline Therapeutics Holdings plc

Freeline Therapeutics Holdings plc

FRLN
Freeline Therapeutics Holdings plcUS flagNASDAQ Global Select
6.49
USD
+0.01
- -
28.28MMarket Cap

Total Valuation

Freeline Therapeutics Holdings plc carries a market capitalization of 28.28M, placing it among publicly traded companies globally.

Market Cap28.28M
Enterprise ValueN/A

Stock Price Statistics

Freeline Therapeutics Holdings plc's stock has gained approximately 3.01587% over the past 52 weeks. The 50-day moving average sits at 6.40, while the 200-day moving average is 4.57.

Beta (5Y)N/A
52-Week Price Change3.01587%
50-Day Moving Average6.40
200-Day Moving Average4.57
Average Volume (20 Days)N/A

Stock Splits

Freeline Therapeutics Holdings plc's most recent stock split took place on May 12, 2023 with a 15:1 split ratio.

Last Split Date5/12/2023
Split Ratio15:1